School of Medicine
Showing 1-47 of 47 Results
-
Sepideh Bajestan, MD, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests Neuropsychiatry
Functional Neurological Symptom Disorders, Psychogenic Non-Epileptic Seizures
Group and Individual Psychotherapy
Impulse Control Disorders -
Tali Ball, PhD
Instructor, Psychiatry and Behavioral Sciences
Bio Tali Ball, PhD is the Director of the Stanford Translational Anxiety Research (STAR) Lab and an Instructor in the Stanford Department of Psychiatry and Behavioral Sciences. Her primary research aim is to translate neurobiologically-based models of anxiety into improved treatment outcomes. She received her PhD in Clinical Psychology from the SDSU/UCSD Joint Doctoral Program, where her dissertation work established relationships between brain activation during fear extinction learning and anxiety reduction following a brief exposure intervention. Her postdoctoral research focused on developing clinically useful metrics of brain circuit function and incorporating neuroscience-based assessments into clinical practice. Her work brings together clinical psychology, neuroscience, and computational approaches, always with an eye towards how the results of the science can be directly implemented in clinical practice.
-
Jacob S. Ballon
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Bio Jacob S. Ballon, M.D., M.P.H. specializes in the treatment of people with psychotic disorders including schizophrenia. He is the Co-Director of the INSPIRE Clinic at Stanford which provides interdisciplinary care for people experiencing psychosis. He is also the medical director of H2 acute inpatient unit and the co-director of the specialty psychiatry clinics section in the Department of Psychiatry. Dr. Ballon completed his residency at Stanford in 2009 and a Schizophrenia Research Fellowship at Columbia University in 2011.
INSPIRE is an innovative interdisciplinary client-centered resource providing respectful evidence-based care to support people to achieve meaningful recovery from psychosis through collaborative partnership with individuals and their families while advancing knowledge and training for a new generation of providers. With a recovery-oriented philosophy, the clinic provides an array of services including psychopharmacology, psychotherapy, and psychosocial evaluations. As a research clinic, they are focused on collaborating with multiple disciplines throughout the university to conduct clinical and basic science research including functional imaging, clinical trials, basic pathophysiology, and genetics.
Dr. Ballon maintains an interest in understanding the connections between the brain and the rest of the body as relates to the manifestation and treatment of people who experience psychosis. He co-chairs a diverse working group that brings together researchers from throughout the university and technology community to investigate these connections and look at innovative ways to combine large-scale data to elucidate new strategies for developing pathways to prevention or treatment of psychosis. He has active projects investigating the metabolic implications of schizophrenia and of psychiatric medication including the association of antipsychotic medication with weight gain and insulin resistance.
In understanding the whole-body impact of psychiatric illness, Dr. Ballon also has an active interest in the role that exercise can play in psychiatric treatment. He co-chairs Brain-Ex, a multidisciplinary research partnership of clinical research, neuroscience, exercise physiology, and prevention medicine to build the capacity to study the impact of physical exercise on brain response, reward pathways, neuroprotection, and prevention of psychiatric disorders. This program aims to study the neurobiology of elite athletic performance, sustained exercise behavior, and the subjective experience of exercise, as well as the potential for exercise to prevent and reverse neurodegenerative psychiatric disorders. He is the site-principal investigator of an NIMH-funded clinical trial looking at the use of aerobic exercise to improve cognition in people with schizophrenia. -
Belinda Bandstra
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Bio Belinda S. Bandstra, MD, MA, is Clinical Associate Professor, Assistant Director of Residency Training, and Chief of the General Resident Continuity Clinic in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She supervises residents in the General Clinic, Evaluation Clinic, Individual Psychotherapy Clinic and Psychosocial Treatment Clinic, in addition to maintaining a small general clinical practice of her own. Dr. Bandstra has specific interests in issues of culture in psychiatry, transitional age mental health, and mental health and wellness in academia.
Dr. Bandstra also teaches extensively in the Adult Psychiatry Residency Training Program. She co-directs residency coursework in: Sociocultural Issues in Psychiatry; Leadership, Scholarship, and Career Development; and Essentials of Psychiatry. Dr. Bandstra is a member of the Association for Academic Psychiatry and the American Association of Directors of Psychiatric Residency Training. -
Michele Barry, MD, FACP
Drs. Ben & A. Jess Shenson Professor, Senior Associate Dean, Global Health, Director, Center for Innovation in Global Health, Professor of Medicine & Senior Fellow at the Woods Institute and at the Freeman Spogli Institute
Current Research and Scholarly Interests Areas of research
Ethical Aspects of research conducted overseas
Clinical Tropical Diseases
Globalization's Impact upon Health Disparities
Hemorrhagic Viruses -
Fiona Barwick
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Stanford Center for Sleep Sciences and Medicine
Current Research and Scholarly Interests Research interests focus on expanding sleep education, improving sleep health, optimizing treatment for circadian rhythm disorders, and adapting treatment for insomnia in populations where developmental, medical, psychiatric and cultural factors intersect.
Current research projects include developing and piloting integrated protocols for treating sleep problems that co-occur with medical conditions such as chronic pain or POTS. Ongoing collaborations include delivery of a CBTI protocol in Mandarin via telehealth to patients at Chongqing Traditional Chinese Medicine Hospital in China. Past projects include investigation of the link between RLS and the gut microbiome and a survey of student sleep health. -
Nataly Sumarriva Beck
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests Dr. Beck's clinical research includes the relationship between catatonia and substance use. In addition, she works on first-episode psychosis, with a focus on treatments in the young adult population.
-
Catherine Benedict
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests My research focuses on improving cancer survivorship through better understanding of long-term health outcomes and through the development of theoretically driven, evidence-based behavioral interventions to improve adjustment, risk management, and quality of life. To this end, I lead studies aimed to guide and support patient decision-making and self-management after cancer. Much of my work focuses on the experiences of young adults affected by cancer.
-
Ori-Michael Johanan Benhamou
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Bio Dr. Benhamou received his Bachelor's degree at Duke University and went on to complete medical school at Ben-Gurion University. He completed his residency in Psychiatry at Westchester Medical Center and fellowship in Addiction Medicine at Stanford. He has published works in the areas of suicide, autoimmune encephalitis and addiction. His current interests include substance abuse, the role of transcranial magnetic stimulation on addiction and the intersection of suicide and substance abuse.
-
Brandon S. Bentzley, MD, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Bio Dr. Bentzley is a psychiatrist and Instructor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine.
His clinical interests include the treatment of substance use disorders and depression using advanced techniques and technologies such as neurostimulation. His research interests include advances in neurostimulation-based treatments, suicide prevention and neuroeconomics.
As a postdoctoral fellow, Dr. Bentzley was the recipient of a National Institute of Mental Health research training grant. Currently, he is principal investigator on a study funded by the National Institute on Drug Abuse that focuses on understanding the role of dopamine in economic decision making. Further, Dr. Bentzley is co-investigator of a study that received grant support from the American Foundation for Suicide Prevention. This randomized, controlled trial investigates ketamine therapy with a transition to buprenorphine for the treatment of acute suicidality. The study is scheduled for completion in 2022.
Dr. Bentzley is also a consultant for industry innovators, such as an organization conducting research into new treatments for opioid use disorder and another focusing on data science and psychometrics.
He has authored articles on surgically implanted neuromodulatory technology for treatment-resistant depression, the origins of selective vulnerability to opioid addiction, the antidepressant effects of ketamine, the role of neurons in cocaine demand, and other topics.
His work has appeared in the American Journal of Psychiatry, Proceedings of the National Academy of Sciences, Molecular Psychiatry, and elsewhere. In addition, he is a reviewer for the Journal of Substance Abuse Treatment, European Journal of Neuroscience, Behavioural Brain Research, and Addiction Biology.
Dr. Bentzley has delivered invited lectures including psychiatry grand grounds at Stanford and other medical centers. He has held leadership positions on committees focused on medical education and residency programs, among them Stanford?s Psychiatry Residency Neuroscience Curriculum Committee and the Psychiatry Residency Wellbeing Committee.
Dr. Bentzley has received honors for his scholarship. He was a member of a team that won the American Psychiatric Association?s ?MindGames? national residency competition, was a Ruth Fox Scholar, as designated by the American Society of Addiction Medicine, and won the Distinguished Graduate of the Year Award from the Medical University of South Carolina.
He is a member of the American Psychiatric Association, American Society of Addiction Medicine, American Society for Neurosciences, and American Association for the Advancement of Science. Dr. Bentzley has provided community outreach mental health services as a clinical volunteer. -
Michele Berk
Assistant Professor of Psychiatry and Behavior Sciences (Child and Adolescent Psychiatry and Child Development) at the Stanford University Medical Center
Current Research and Scholarly Interests The focus of my research is on adolescent suicidal and self-harm behavior. I am currently one of four Principal Investigators of a multisite NIMH-sponsored RCT of DBT for adolescents at high risk for suicide (NCT01528020: Collaborative Adolescent Research on Emotions and Suicide [CARES], PI: Linehan, McCauley, Berk, & Asarnow) aimed at evaluating the efficacy of DBT with adolescents compared to a combined individual and group supportive therapy control condition (IGST).
-
Rebecca Bernert
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Bio Dr. Bernert is Founding Director of the Suicide Prevention Research Laboratory, and Co-Chairs a special departmental initiative to develop a Center for Premature Mortality and Suicide Prevention. She is a suicidologist, with subspecialty expertise in suicide prevention clinical trials, standardized suicide risk assessment and best practice management, and the epidemiology of self-directed violence. She has subspecialty training in behavioral sleep medicine, with a background in sleep and circadian physiology. Her program utilizes cognitive, biologic (e.g., fMRI), and behavioral testing paradigms, with an emphasis on translational therapeutics. Dr. Bernert has collaborated with NIH, DOD, DARPA, SAMHSA, and CDC on suicide prevention initiatives; and recently served as a content expert for the White House 2015 Open Data and Innovation for Suicide Prevention #Hackathon. She has also contributed to the development of clinical practice parameters, including the 2013 VA/DOD Clinical Practice Guidelines for the Assessment and Management of Suicide Risk, with current work underway focused on investigating medical education training in suicide risk assessment and management. Her research focuses on the identification of novel therapeutic targets for suicide prevention across the lifespan, particularly those aiming to reduce stigma and enhance access to care. A specific focus of this work emphasizes the use of rapid-action, low-risk treatment approaches for the prevention of suicide. Dr. Bernert has several suicide prevention trials underway, funded by NIH and DOD, testing the preliminary efficacy of a non pharmacological insomnia treatment on suicidal behaviors. She also has several grants focused on the development of a data monitoring system for the study of local suicide clusters and emergency department based protocols to improve risk detection within pediatric suicide prevention. Our aim is to delineate transdiagnostic risk factors and biomarkers of clinical response that may inform the pathogenesis of risk and treatment innovation. An overarching mission is to harness new technologies within suicide prevention, including artificial intelligence (AI) and mobile health applications, to enhance risk detection and multidisciplinary frameworks. Advisory and advocacy work, and the way in which research guides health policy, dissemination, and national strategies for suicide prevention, represents an extension of this work. This includes recent initiatives to establish national and local guidelines for lethal means restriction and calls for advanced technology use in suicide prevention research and strategy. Last, Dr. Bernert has several pilot projects underway focused on inclusive practices in faculty diversity and development, and the way in which family-friendly policies impact faculty recruitment and retention in academic medicine.
-
Mahendra Bhati
Clinical Professor, Psychiatry and Behavioral Sciences
Bio Dr. Bhati is a board certified neuropsychiatrist with expertise in psychiatric diagnosis, psychopharmacology, and neuromodulation. He completed postdoctoral research studying transcranial magnetic stimulation (TMS) evoked potentials in schizophrenia and was a principle investigator for the DSM-5 academic field trials. His research experience included roles as an investigator in the first controlled clinical trials of deep brain stimulation and low field synchronized TMS for treatment of depression. His current interests include studying TMS-evoked potentials as biomarkers for neuropsychiatric disorders, augmented-reality TMS, closed-loop responsive neurostimulation for treatment of impulse and fear-related disorders, and magnetic resonance guided focused ultrasound for treatment-resistant obsessive compulsive disorder and depression.
-
Cara Bohon
Assistant Professor of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Development) at the Stanford University Medical Center
Current Research and Scholarly Interests My research interests have focused on the neural bases of eating disorders and obesity. I am particularly interested in the way emotion and reward is processed in the brain and how that may contribute to eating behavior and food restriction. I hope to eventually translate biological research findings into treatments.
-
Mariya Borodyanskaya
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child and Adolescent Psychiatry
Bio Dr. Mariya Borodyanskaya enjoys being part of the Stanford Team at Mills, an interdisciplinary team dedicated to supporting adolescents and their families in navigating the challenges of mental health crisis. She maintains a broad set of interests, including Post Traumatic Stress Disorder, Psychotic Disorders and Juvenile Justice system reform. She also enjoys supervising and teaching the Stanford Child & Adolescent Psychiatry fellows.
-
Daniel Bowling
Instructor, Psychiatry and Behavioral Sciences
Bio I am a neuroscientist focused on auditory-vocal function in human social communication. My expertise covers psychological, neurobiological, and acoustic perspectives on speech and music, their conveyance of affect, social-significance, and origins in mammalian vocal behavior. I combine psychophysiological, psychoacoustic, neuroendocrine and pharmacological methods to study perception and behavior in human subjects. I graduated from the University of California San Diego in 2006 with summa cum laude honors in Biological Psychology (BS) and Neurophilosophy (BA). I hold a graduate certificate in Cognitive Neuroscience from Duke University (2009), and a PhD in Neurobiology from Duke University School of Medicine (2012). My postdoc at the University of Vienna (2012-18) focused on bioacoustics and auditory-motor synchrony. My work has been recognized with awards including a young investigator award from the University of Vienna and an innovation award from the Social and Affective Neuroscience society. At Stanford, I am working to develop an objective assessment of auditory-vocal affect perception for clinical research on autism in collaboration with scientists, engineers, and artists from departments of Psychiatry, Psychology, and Music. My work is funded by NIMH and the Wu Tsai Neuroscience Institute. Along the way, I have been fortunate to receive mentorship from Drs. Patricia Churchland, Dale Purves, Tecumseh Fitch, and Karen Parker.
-
Christiane Brems
Clinical Professor, Psychiatry and Behavioral Sciences
Bio Christiane Brems, PhD, ABPP, RYT-500, C-IAYT, received her PhD in Clinical Psychology from Oklahoma State University in 1987. Dr. Brems is licensed as a psychologist in several US states and board-certified as a clinical psychologist by the American Board of Professional Psychology (ABPP). She is a registered yoga teacher (E-RYT500) and certified C-IAYT yoga therapist. She is also certified in Interactive Guided Imagery.
She began her career in academia at the University of Oklahoma Health Sciences Center. She then served on faculty at the University of Alaska Anchorage for 23 years, where she held a variety of leadership positions, including as (Co-Founding) Director of the Center for Behavioral Health Research and Services, (Co-Founding) Director of the PhD Program in Clinical-Community Psychology, and Interim Vice Provost for Research and Dean of the Graduate School. Most recently, she served for nearly six years as Dean and Professor of the School of Graduate Psychology (SGP) at Pacific University Oregon.
Dr. Brems has worked for decades as an applied researcher and clinical practitioner with particular interests in health promotion, rural healthcare delivery, and all things yoga. Her work has been funded by grants and contracts from the National Institutes of Health, the Centers for Dis. Control and Prevention, the Substance Abuse and Mental Health Service Administration, and local and State of Alaska funding sources. She has shared her work extensively in over 120 peer-reviewed journal articles, 100s of technical reports, and several books, including the Comprehensive Guide to Child Psychotherapy (now in its 4th edition), Dealing with Challenges in Psychotherapy and Counseling, Basic Skills in Counseling and Psychotherapy, and others. Dr. Brems is committed to excellence in and integration of clinical services, teaching, consultation, and research.
Dr. Brems has integrated yoga, mindfulness, complementary interventions, and self-care strategies in her work as a consultant, author, dean, teacher, researcher, mentor, supervisor, colleague, and service provider. She values these practices as crucial aspects of day-to-day professional and personal life and seeks to enhance access to them for all who can benefit. -
Kim Bullock, MD
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests Director of Virtual Reality & Immersive Techology (VR-IT) Clinic and Lab.
Use of technology to understand the interaction of sensation, embodiment, and emotional/ behavioral regulation.
Virtual reality treatments as a sensory modulating device to treat disorders involving body image, sensation, and control. Exploration of the use of mirrored visual feedback while inhabiting a virtual avatar to treat pain and somatic symptom related disorders.